3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
51
Neoplasms
29
Prostatic Neoplasms
28
Head and Neck Neoplasms
15
Lung Neoplasms
14
Ovarian Neoplasms
9
Pancreatic Neoplasms
8
Urinary Bladder Neoplasms
6
Sarcoma
6
Oropharyngeal Neoplasms
6
Hematologic Neoplasms
6
Gastrointestinal Neoplasms
6
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
5
Rectal Neoplasms
5
Neoplasm Metastasis
5
Multiple Myeloma
5
Esophageal Neoplasms
5
Endometrial Neoplasms
5
Depression
5
Brain Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Polycystic Ovary Syndrome
4
Motor Activity
4
Melanoma
4
Lymphoma
4
Anxiety Disorders
4
Stomach Neoplasms
3
Pain
3
Osteosarcoma
3
Interventions
Injections
6
pembrolizumab
5
toripalimab
3
tislelizumab
3
senaparib
3
Bevacizumab
3
sintilimab
2
Technetium
2
Specimen Handling
2
Nivolumab
2
Ipilimumab
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Blood Specimen Collection
2
zimberelimab
1
tumor-cells apoptosis factor, human
1
tazemetostat
1
spartalizumab
1
sacituzumab govitecan
1
rucaparib
1
osimertinib
1
olaparib
1
etoposide phosphate
1
enzalutamide
1
envafolimab
1
cemiplimab
1
cedazuridine
1
atezolizumab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
Surveys and Questionnaires
×
1 year
×
Clear all
No trials found.